Status:
NOT_YET_RECRUITING
Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever
Lead Sponsor:
Medical Corps, Israel Defense Force
Conditions:
Relapsing Fever, Tick-Borne
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare standard treatment (5 days of doxycycline) vs single dose doxycycline for the prevention of tick-borne relapsing fever in soldiers who found bite marks on...
Detailed Description
1. In accordance with the guidelines of the Institutional Review Board (IRB), following the completion of the field exercise series, all participating soldiers, both those who actively engaged in the ...
Eligibility Criteria
Inclusion
- Israel Air Force flight course cadets.
Exclusion
- Known sensitivity or allergy to doxycycline
- Fever in the three weeks preceding the performance of the field series
- Suspicion of the Tick borne disease with recurrent fever three weeks before performing the
- Incompletion of the field series
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2027
Estimated Enrollment :
526 Patients enrolled
Trial Details
Trial ID
NCT06045481
Start Date
August 1 2024
End Date
October 31 2027
Last Update
March 13 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.